Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03AGV
|
|||
| Former ID |
DNC012173
|
|||
| Drug Name |
N-(3-Methanesulfonyl-4-methyl-benzoyl)-guanidine
|
|||
| Synonyms |
SCHEMBL9194592
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C10H13N3O3S
|
|||
| Canonical SMILES |
CC1=C(C=C(C=C1)C(=O)N=C(N)N)S(=O)(=O)C
|
|||
| InChI |
1S/C10H13N3O3S/c1-6-3-4-7(9(14)13-10(11)12)5-8(6)17(2,15)16/h3-5H,1-2H3,(H4,11,12,13,14)
|
|||
| InChIKey |
LHXXNXYVTIIVIY-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Sodium/hydrogen exchanger 1 (SLC9A1) | Target Info | Inhibitor | [1] |
| Sodium/hydrogen exchanger 3 (SLC9A3) | Target Info | Inhibitor | [1] | |
| KEGG Pathway | Proximal tubule bicarbonate reclamation | |||
| Protein digestion and absorption | ||||
| Bile secretion | ||||
| Mineral absorption | ||||
| cAMP signaling pathway | ||||
| Cardiac muscle contraction | ||||
| Adrenergic signaling in cardiomyocytes | ||||
| Regulation of actin cytoskeleton | ||||
| Thyroid hormone signaling pathway | ||||
| Salivary secretion | ||||
| Gastric acid secretion | ||||
| Pancreatic secretion | ||||
| Proteoglycans in cancer | ||||
| Pathway Interaction Database | Endothelins | |||
| RhoA signaling pathway | ||||
| ErbB1 downstream signaling | ||||
| Signaling mediated by p38-alpha and p38-beta | ||||
| Reactome | Hyaluronan uptake and degradation | |||
| WikiPathways | SIDS Susceptibility Pathways | |||
| Regulation of Actin Cytoskeleton | ||||
| G Protein Signaling Pathways | ||||
| Glycosaminoglycan metabolism | ||||
| Osteoclast Signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | (2-Methyl-5-(methylsulfonyl)benzoyl)guanidine Na+/H+ antiporter inhibitors. J Med Chem. 1997 Jun 20;40(13):2017-34. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.